Viewing Study NCT00006028


Ignite Creation Date: 2025-12-26 @ 10:34 AM
Ignite Modification Date: 2025-12-31 @ 12:04 PM
Study NCT ID: NCT00006028
Status: COMPLETED
Last Update Posted: 2013-05-27
First Post: 2000-07-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Gemcitabine Plus Cisplatin in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Is Recurrent or Has Not Responded to Platinum-based Chemotherapy
Sponsor: Gynecologic Oncology Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module